Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 2
2019 2
2020 1
2021 3
2022 9
2023 7
2024 12
2025 11
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation.
Mussini C, Giacomelli A, Quiros-Roldan E, Mazzotta V, Di Biagio A, De Vito A, Costantini A, D'Ettorre G, Giacometti A, Vergori A, Tavelli A, Malagnino V, Castagna A, Chester J, Antinori A, d'Arminio Monforte A, Cozzi-Lepri A; Icona Foundation Cohort Study for the Icona Foundation Study Group. Mussini C, et al. EClinicalMedicine. 2025 Jul 24;86:103368. doi: 10.1016/j.eclinm.2025.103368. eCollection 2025 Aug. EClinicalMedicine. 2025. PMID: 40740293 Free PMC article.
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study).
Gagliardini R, Camici M, Lanini S, Bellagamba R, Ottou S, Plazzi MM, Vergori A, Mazzotta V, Mondi A, Fusto M, Paulicelli J, Tempestilli M, Pinnetti C, Grilli E, Mastrorosa I, De Zottis F, Duca GD, Antinori A. Gagliardini R, et al. Among authors: mastrorosa i. Int J Infect Dis. 2025 Sep;158:107961. doi: 10.1016/j.ijid.2025.107961. Epub 2025 Jun 18. Int J Infect Dis. 2025. PMID: 40541768 Free article.
Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findings.
Camici M, Piano Mortari E, Del Duca G, Cimini E, Mazzotta V, De Ponte C, Mastrorosa I, Mazzotta S, Pinnetti C, Notari S, Bordoni V, Gili S, Prencipe G, Maggi F, Carsetti R, Girardi E, Antinori A, Agrati C. Camici M, et al. Among authors: mastrorosa i. Lancet Infect Dis. 2026 Mar 31:S1473-3099(26)00063-0. doi: 10.1016/S1473-3099(26)00063-0. Online ahead of print. Lancet Infect Dis. 2026. PMID: 41932347 Review.
Salivary cortisol in long COVID: a marker of broader stress system and circadian rhythm dysregulation.
Camici M, Franco M, Talamanca L, Petino M, Paulicelli J, Scarnecchia L, Ciavarella L, Orzilli T, Balducelli F, Mazzotta V, Mastrorosa I, Cimini E, Tartaglia E, Notari S, Maggi F, Girardi E, Baldelli R, Zuppi P, Antinori A. Camici M, et al. Among authors: mastrorosa i. Front Cell Infect Microbiol. 2026 Jan 6;15:1690698. doi: 10.3389/fcimb.2025.1690698. eCollection 2025. Front Cell Infect Microbiol. 2026. PMID: 41568000 Free PMC article.
HIV infection among adolescents and young adults in Italy: Epidemiology, viro-immunological and treatment outcomes.
Fusco FM, Mastrorosa I, Vichi F, Cervo A, Saracino A, Calza L, Quiros-Roldan E, Teti ME, Costantini A, Cingolani A, Girardi E, Antinori A, Monforte AD, Tavelli A; ICONA Foundation Study Group. Fusco FM, et al. Among authors: mastrorosa i. Int J Infect Dis. 2026 Feb;163:108200. doi: 10.1016/j.ijid.2025.108200. Epub 2025 Nov 15. Int J Infect Dis. 2026. PMID: 41242692 Free article.
Innate and SARS-CoV-2 specific adaptive immune response kinetic in neutralizing monoclonal antibody successfully treated COVID-19 patients.
Casetti R, Sacchi A, Mazzotta V, Cristofanelli F, Grassi G, Gili S, Cimini E, Notari S, Bordoni V, Mastrorosa I, Giancola ML, Vergori A, Tempestilli M, Vita S, Mariotti D, Rosati S, Lalle E, Meschi S, Colavita F, Garbuglia AR, Girardi E, Nicastri E, Antinori A, Agrati C. Casetti R, et al. Among authors: mastrorosa i. Int Immunopharmacol. 2025 Feb 20;148:113934. doi: 10.1016/j.intimp.2024.113934. Epub 2025 Jan 19. Int Immunopharmacol. 2025. PMID: 39832460
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV.
Vergori A, Cozzi Lepri A, Cicalini S, Matusali G, Bordoni V, Lanini S, Meschi S, Iannazzo R, Mazzotta V, Colavita F, Mastrorosa I, Cimini E, Mariotti D, De Pascale L, Marani A, Gallì P, Garbuglia A, Castilletti C, Puro V, Agrati C, Girardi E, Vaia F, Antinori A; HIV-VAC study group. Vergori A, et al. Among authors: mastrorosa i. Nat Commun. 2022 Aug 22;13(1):4922. doi: 10.1038/s41467-022-32263-7. Nat Commun. 2022. PMID: 35995780 Free PMC article.
Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects.
Cimini E, Vergori A, Cimaglia C, Tartaglia E, Notari S, Colavita F, Matusali G, Mastrorosa I, Mazzotta V, Chinello P, Mencarini P, Giancola ML, Abdeddaim A, Casetti R, Grassi G, Gili S, Cristofanelli F, Maggi F, Piselli P, Girardi E, Antinori A, Camici M. Cimini E, et al. Among authors: mastrorosa i. Int J Mol Sci. 2025 Oct 27;26(21):10412. doi: 10.3390/ijms262110412. Int J Mol Sci. 2025. PMID: 41226453 Free PMC article.
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH.
Gagliardini R, Vergori A, Lorenzini P, Cicalini S, Pinnetti C, Mazzotta V, Mondi A, Mastrorosa I, Camici M, Lanini S, Fusto M, Paulicelli J, Plazzi MM, Marchioni L, Agrati C, Garbuglia AR, Piselli P, Nicastri E, Taglietti F, Palmieri F, D'Offizi G, Girardi E, Vaia F, Antinori A. Gagliardini R, et al. Among authors: mastrorosa i. J Clin Med. 2022 Mar 11;11(6):1546. doi: 10.3390/jcm11061546. J Clin Med. 2022. PMID: 35329872 Free PMC article.
49 results